MedPath

Therapeutic effect of Montelukast in patients with oral lichen planus

Phase 3
Conditions
ichen Planus.
Lichen Planus
Registration Number
IRCT2012110811389N2
Lead Sponsor
Vice Chancellor for Research , Hamedan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
200
Inclusion Criteria

Inclusion criteria : (1) Diagnosis of OLP will be carried out by clinical history , physical exams and histopathological findings. (2) All of the patients should not use medication for at least two months. (3) They should not have systemic diseases such as diabetes mellitus, hepatitis and trauma history. Exclusion criteria : Patient is non-compliant with treatment until end of study.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Size of lesion. Timepoint: Study onset/after 2,4,6,8,10,12 weeks. Method of measurement: Ruler or flexible surgical probe.;Pain rate. Timepoint: Study onset/after 2,4,6,8,10,12 weeks. Method of measurement: Visual Analogue Scaling.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath